More recently, we showed that blocking autophagy by either FIP200 deletion or specifically block its canonical autophagy functions essentially alleviated the development of mammary tumors in the MMTV-Neu mouse model of breast cancer by perturbing the trafficking of oncogenic driver HER2 itself and promoting its release from tumor cells37. This evidence concerns the gene ERBB2 and breast cancer.